Target intelligence / Profile preview

PARL pseudogene 2 (PARLP2)

Target
PARLP2
Molecular classification
Other (Pseudogene)
01

Overview

**PARL pseudogene 2 (PARLP2)** is classified as a pseudogene based on genome annotation and public gene databases[3][5][7]. Pseudogenes are genomic DNA sequences similar to known genes but generally lack protein-coding potential due to mutations, deletions, or truncations. PARLP2 is located on chromosome 6 (chr6:143342246-143343383, hg38) and has no known protein product, functional role, or therapeutic relevance[3][5][7]. There is no evidence that PARLP2 encodes a functional receptor, enzyme, transporter, or any protein with biological activity in humans. It does not participate in any recognized molecular pathway, does not serve as a disease biomarker, and is not targeted by therapeutics[3][5][7]. It is accurately classified as a pseudogene and not as a therapeutic or diagnostic target. Returned information is based on current gene annotation databases, which agree that PARLP2 lacks biological, molecular, or clinical relevance as a protein-coding gene.

Other names
PARLP2PARL pseudogene 2

Beyond the preview

Go deeper on PARL pseudogene 2 (PARLP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PARL pseudogene 2 (PARLP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call